Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
21por Ayers, Emily C., Wilson, Jeffrey, Canderan, Glenda, Keshavarz, Behnam, Woodfolk, Judith, Portell, Craig A., Williams, Michael E.“…Portell: Abbvie: Research Funding; Aptitude Health: Honoraria; Merck: Honoraria, Research Funding; Xencor: Research Funding; Pharmacyclics: Honoraria; BeiGene: Honoraria, Research Funding; Targeted Oncology: Honoraria; Morphosys: Honoraria; SeaGen: Research Funding; TG Therapeutics: Honoraria, Research Funding; Acerta/AstraZeneca: Research Funding; Kite: Honoraria, Research Funding; Genentech: Research Funding; VelosBio: Research Funding. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
22por Rubinstein, Samuel, Lynch, Ryan C., Desai, Aakash, Stratton, Catherine, Jha, Alokkumar, Bakouny, Ziad, Schmidt, Andrew, Sica, R. Alejandro, Bhutani, Divaya, Shah, Dimpy P., Wall, Sarah A, Lyman, Gary H., Kuderer, Nicole M., Weiss, Matthias, Warner, Jeremy L., Stockerl-Goldstein, Keith E., Mesa, Ruben, Thompson, Michael A.“…[Figure: see text] DISCLOSURES: Lynch:Bayer: Research Funding; Rhizen Pharmaceuticals: Research Funding; Incyte: Research Funding; TG Therapeutics: Research Funding; Takeda: Research Funding; Juno Therpeutics: Research Funding; Genentech: Research Funding; MorphoSys: Consultancy; Cyteir: Research Funding. Bakouny:BMS: Research Funding; Genentech: Research Funding. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23por Wood, William A., Neuberg, Donna S., Thompson, John Colton, Tallman, Martin S., Sekeres, Mikkael A., Sehn, Laurie H., Anderson, Kenneth, Goldberg, Aaron D, Pennell, Nathan A, Niemeyer, Charlotte M., Tucker, Emily, Hewitt, Kathleen, Plovnick, Robert M, Hicks, Lisa K.“…Hoffmann-La Roche Ltd: Consultancy, Honoraria, Research Funding; MorphoSys: Consultancy, Honoraria; Merck: Consultancy, Honoraria; Lundbeck: Consultancy, Honoraria; Genentech, Inc.: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Honoraria; Verastem Oncology: Consultancy, Honoraria. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24por Ghandili, Susanne, Niederwieser, Christian, Weisel, Katja, Bokemeyer, Carsten, Fiedler, Walter, Modemann, Franziska“…Fiedler: Novartis: Honoraria; Pfizer: Consultancy, Honoraria, Research Funding; Daiichi Sanyko: Consultancy, Other: Meeting attendance, Preparation of information material; Stemline: Consultancy; Servier: Consultancy, Other: Meeting attendance, Preparation of information material; MorphoSys: Consultancy, Honoraria; Jazz: Consultancy, Honoraria, Other: Meeting attendance, Preparation of information material; Celgene: Consultancy, Honoraria; Ariad/Incyte: Honoraria; Amgen: Consultancy, Honoraria, Other: Meeting attendance, Preparation of information material, Patents & Royalties, Research Funding; Abbvie: Consultancy, Honoraria, Other: Meeting attendance, Preparation of information material. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
25por Leiva, Orly, Campia, Umberto, Snyder, Julia, Barns, Briana, Rizzo, Samantha, Khairani, Candrika, Al-Samkari, Hanny, Karp Leaf, Rebecca, Rosovsky, Rachel P., Goodarzi, Katayoon, Fathi, Amir T., Goldhaber, Samuel Z., Piazza, Gregory, Hobbs, Gabriela“…Fathi: Agios/Servier: Consultancy, Other: Clinical Trial Support; BMS: Consultancy, Other: Clinical Trial Support; AbbVie: Consultancy, Other: Clinical Trial Support; Pfizer: Consultancy; Trillium: Consultancy; Kura: Consultancy; Blueprint Medicines Corporation: Consultancy; Genentech: Consultancy; Novartis: Consultancy; Trovagene: Consultancy; Daiichi Sankyo: Consultancy; Novartis: Consultancy; Morphosys: Consultancy; Kite: Consultancy; Foghorn: Consultancy; Takeda: Consultancy; Amgen: Consultancy; Seattle Genetics: Consultancy; NewLink Genetics: Consultancy; Forty Seven: Consultancy; Ipsen: Consultancy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
26por Padron, Eric, Hebert, Donnie, Gore, Steven D., Gillis, Nancy, Komrokji, Rami S., Saber, Wael, Al Baghdadi, Tareq, Liu, Jane Jijun, Gorak, Edward J., Lee, Cecilia, Borchert, Christine, Wilson, Steffanie H., Thompson, Jason, Walker, Mary Ellen, DiFronzo, Nancy L., DeZern, Amy E., Sekeres, Mikkael A.“…Al Baghdadi: Bristol-Myers Squibb: Current holder of individual stocks in a privately-held company, Membership on an entity's Board of Directors or advisory committees; AstraZeneca: Current holder of individual stocks in a privately-held company; Epizyme: Current holder of individual stocks in a privately-held company; Heron Therapeutics: Current holder of individual stocks in a privately-held company; Morphosys: Membership on an entity's Board of Directors or advisory committees; Karyopharm: Membership on an entity's Board of Directors or advisory committees; Cardinal Health: Membership on an entity's Board of Directors or advisory committees. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
27por Choi, Yun, Caro, Jessica, Li, Xiaochun, Al-Obeidi, Arshed, Kurtz, Sharyn Lynn, Kim, Austin I., Chang, Julie E., Olszewski, Adam J., Zayac, Adam, Matthews, Andrew, Barta, Stefan K., Sundaram, Suchitra, Hernandez-Ilizaliturri, Francisco J., Leslie, Lori A., Caimi, Paolo, Carter, Jordan, David, Kevin A., Evens, Andrew M., Kim, Myung Sun, Nagle, Sarah J., Goldberg, Judith, Diefenbach, Catherine S.“…Diefenbach: Bristol-Myers Squibb: Consultancy, Honoraria, Research Funding; Merck Sharp & Dohme: Consultancy, Honoraria, Research Funding; Morphosys: Consultancy, Honoraria, Research Funding; Genentech, Inc./ F. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
28por Svoboda, Jakub, Ballard, Hatcher J, Ho, Carrie I, Hughes, Mitchell E., Chong, Elise A, Duca, Adam, Prischak, Sara, Dwivedy Nasta, Sunita, Ruella, Marco, Landsburg, Daniel J, Barta, Stefan K., Gerson, James N, Schuster, Stephen J.“…Landsburg: Triphase: Research Funding; Takeda: Research Funding; Curis: Research Funding; ADCT: Membership on an entity's Board of Directors or advisory committees; Incyte: Membership on an entity's Board of Directors or advisory committees; Karyopharm: Membership on an entity's Board of Directors or advisory committees, Other: DSMB member; Morphosys: Membership on an entity's Board of Directors or advisory committees. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
29por Ip, Andrew, Mato, Anthony, Intrator, Jordan, Howard, Nicholas P, Petrillo, Alessandra, Vicioso, Rosalba, Sebti, Rani, Cicogna, Cristina, Magarelli, Gabriella, Leslie, Lori A., Goy, Andre H., Feldman, Tatyana A.“…Goy:Constellation: Research Funding; Genentech/Roche: Research Funding; Infinity: Research Funding; Karyopharm: Research Funding; Morphosys: Research Funding; AbbVie: Research Funding; MD Anderson: Research Funding; Regional Cancer Care Associates/OMI: Current Employment; Infinity Verastem: Research Funding; Xcenda: Consultancy; Hackensack UMC and University of Nebraska: Research Funding; COTA: Consultancy, Current equity holder in publicly-traded company, Other: leadership role; Kite, a Gilead Company: Consultancy, Current equity holder in publicly-traded company, Honoraria, Other: leadership role, Research Funding; Janssen: Consultancy, Honoraria, Other: leadership role, Research Funding; Celgene: Honoraria, Research Funding; AstraZeneca: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: leadership role, Research Funding; Acerta: Consultancy, Honoraria, Other: leadership role, Research Funding; RCCA/OMI: Current Employment; PracticeUpdate Oncology: Consultancy; Bayer: Research Funding; CALBG: Research Funding. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
30por Wiedmeier, Julia E., Iqbal, Madiha, Munoz, Javier, Bezerra, Evandro D., Garcia Robledo, Juan Esteban, Bansal, Radhika, Johnston, Patrick B., Hathcock, Matthew, Larsen, Jeremy T., Bergsagel, P. Leif, Wang, Yucai, Reeder, Craig B., Leis, Jose F., Fonseca, Rafael, Palmer, Jeanne M., Warsame, Rahma M, Kourelis, Taxiarchis, Hayman, Suzanne R., Dingli, David, Kapoor, Prashant, Kumar, Shaji, Durani, Urshila, Villasboas, Jose C., Paludo, Jonas, Bennani, N. Nora, Ansell, Stephen M., Castro, Januario E, Kharfan-Dabaja, Mohamed A., Lin, Yi, Vergidis, Paschalis, Murthy, Hemant S., Rosenthal, Allison C.“…Wang: Incyte: Membership on an entity's Board of Directors or advisory committees, Research Funding; LOXO Oncology: Membership on an entity's Board of Directors or advisory committees, Research Funding; Genentech: Research Funding; InnoCare: Research Funding; Novartis: Research Funding; MorphoSys: Research Funding; Eli Lilly: Membership on an entity's Board of Directors or advisory committees; TG Therapeutics: Membership on an entity's Board of Directors or advisory committees. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto